Zero Tolerance Anti-Doping Newsletter
Volume 3, Issue 2 - March 2006
In This Issue
USA Track & Field CEO Craig A. Masback and USATF President Bill Roe developed the plan in concert with the USATF Board of Directors in October 2003 by combining existing programs and USATF priorities with ambitious new initiatives. "Zero Tolerance" focuses on three goals: increasing efforts to catch and punish cheaters; expanding educational efforts and focusing the message on the theme that cheating is wrong and cheaters will be caught; and taking a more visible role on these issues.
WADA has announced the launch of their new Doping Quiz, an online interactive tool to educate athletes about the dangers and consequences of doping.
The Doping Quiz, an integral part of WADA's Athlete Outreach Program (as seen at the 2005 Helsinki World Championships), can be played in nine different languages, including English, French, Spanish, Italian, German, Greek, Chinese, Portuguese, and Russian.
Test your knowledge about the fight against doping in sport and play the Doping Quiz.
The anti-doping section of the IAAF website has recently undergone a small upgrade, designed to make it easier for you to navigate, and quicker to locate the key information about the IAAF doping control program - www.iaaf.org/antidoping.
Among the latest additions to the site is a new "statistics" section which provides figures from the IAAF doping control program, as well as a list of anti-doping rule violations in 2005. These statistics will be continually updated and more information added in the near future. The addition of the statistics section is in line with the IAAF's commitment to increase the transparency of its doping control program
If you have any suggestions for the improvement of the site, or some information you believe is missing, please contact the IAAF Medical & Anti-Doping Department by email on firstname.lastname@example.org
Get your advantage with USADA's Athlete's Advantage program, which provides tools and resources to athletes more easily comply with anti-doping rules and policies.
The Athlete's Advantage Toolkit is a handy three-ring calendar binder containing important USADA publications, and is available to athletes in the Out-of-Competition (OOC) testing program. USADA launched the Athlete's Advantage Online to help athletes in the OOC testing program to learn how and where to access anti-doping resources. Athletes in the OOC testing program can sign up to receive the Toolkit while going through the online project, by e-mailing email@example.com or calling (866) 601-2632 x 2044 or 719-785-2044. USADA publications are available to all athletes.
Get your advantage now by visiting www.usantidoping.org/advantage. For information about permitted and prohibited medications, use USADA's Drug Reference Online - www.usantidoping.org/dro, or call the Drug Reference Line at (800) 233-0393.
In response to an increase in the use of Beta-2 Agonists by athletes, the IAAF Council has endorsed a recommendation from the IAAF Medical and Anti-Doping Commission to require more detailed information from applicants who seek an exemption for the use of Beta-2 Agonists for asthma and/or exercise-induced asthma or exercise-induced bronchoconstriction, and/or other clinical respiratory diseases requiring specific treatment.
Applicants seeking the use of the four Beta-2 Agonists (formeterol, salbutamol, salmeterol and terbutaline) will be required to submit the following information:
The IAAF has also developed a Detailed Medical Records form that athletes can take to their physician to have them complete the form and control the amount of detailed medical records that are submitted to the IAAF. This application can be download at www.iaaf.org/antidoping.
For athletes who have well-controlled asthma with negative response to all the tests - the IAAF has acknowledged the exceptional cases of athletes with known, but well-controlled, asthma reporting 'negative' results from the bronchial provocation tests, while applying for the use of inhaled Beta-2 Agonists, the following documentation must be enclosed, in addition to negative results obtained in the bronchial provocation tests: a complete report from personal physician on medical history, including reports on hospital emergency department attendance or admission for acute exacerbations of asthma and on previous treatment with different medications, including systemic corticosteroids, and any additional information that might be helpful for the diagnosis.
Athletes who have questions regarding these changes to the IAAF Protocol are encouraged to contact USADA's Camila Zardo at 719-785-2045 as they begin the application process or the application renewal process.
The World Anti-Doping Agency (WADA) 2006 Prohibited List will go into effect on January 1, 2006. Below are some of the key changes that may affect you directly. For the complete list, please go to www.wada-ama.org.
Substances and Methods Prohibited at All Times (In- and Out-of Competition)
S1. Anabolic Agents
1. Anabolic androgenic steroids
Desoxymethyltestosterone (designer steroid), methasterone, prostanozol and methyl-1-testosterone are added to the list of examples.
As described in the Explanatory Note of the 2005 List, that an Adverse Analytical Finding for 19-norandrosterone reported by a laboratory is sufficient proof and does not require further follow-up tests.
Clarifies that drosperinone, a progestative with mild diuretic properties, is not prohibited (as indicated in the Explanatory Note of the 2005 Prohibited List).
Substances and Methods Prohibited In-Competition
Adrenaline, which previously was exemplified in a footnote only, is now clearly named in the list of stimulants.
Some stimulants considered prohibited but not previously listed as examples in the 2004 and 2005 List, are re-introduced to the list of examples for clarification. Therefore, cropropamide, crotetamide, etamivan, heptaminol, isometheptene, and the isomers of methylamphetamine (levmethamfetamine, methamphetamine (D-), p- methamphetamine, ortetamine, phenpromethamine, propylhexedrine) are re-introduced as examples.
New examples of stimulants are added based on chemical structure or biological effect(s): cyclazodone, fenbutrazate, meclofenoxate, norfenefrine, octopamine, oxilofrine, pentetrazol, sibutramine.
Topical preparations, to treat aural/otic, nasal, buccal cavity and ophthalmic ailments, no longer require a Therapeutic Use Exemption due to a wide medical use and the absence of doping potential for these routes of administration.
USADA recently posted the 2006 USADA/WADA Prohibited Substances and Prohibited Methods Wallet Card online for athletes, coaches and trainers to download and print for reference. The Wallet Cards will also be available at various Visa Championship Series Events throughout the indoor and outdoor season.
Visit the USADA website for the updated Wallet Cards (PDF).
Please note that the list online is not complete and is subject to change. USATF recommends that athletes call the USADA Drug Reference line with questions about medications not listed on the Wallet Card at 1-800-233-0393.
|April 1-2||IAAF World Cross Country Championships, Fukuoka, JPN|
|April 9||USA 20 km Race Walk Championships, Hauppage, NY|
|April 29||USA vs. The World at the Penn Relays, Philadelphia, PA|
|May 21||adidas Track Classic, Carson, CA|
|May 28||Nike Prefontaine Classic, Eugene, OR|
|June 3||Reebok Grand Prix, New York, NY|
|June 21-25||AT&T USA Outdoor Track & Field Championships, Indianapolis, IN|
USA Track & Field has recently updated our in-house phone system, and all staff members now have a direct-dial number. Please visit our online organizational directory to see the numbers of USATF staff members you call regularly so you can update your records to reflect the new direct-dial numbers.